{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:53:47Z","timestamp":1783508027856,"version":"3.55.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/jac\/dky103","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T20:12:00Z","timestamp":1520626320000},"page":"1917-1929","source":"Crossref","is-referenced-by-count":17,"title":["Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015\u201316"],"prefix":"10.1093","volume":"73","author":[{"given":"Herbert A","family":"Mbunkah","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"},{"name":"Life Science Zurich Graduate School, Microbiology and Immunology PhD Programme, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Marzel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmutz","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik Lim","family":"Kok","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Zagordi","sequence":"additional","affiliation":[{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Shilaih","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndi N","family":"Nsanwe","sequence":"additional","affiliation":[{"name":"Regional Hospital Bamenda, PO Box 863, Mankon-Bamenda, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyongetah T","family":"Mbu","sequence":"additional","affiliation":[{"name":"Regional Hospital Bamenda, PO Box 863, Mankon-Bamenda, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia M","family":"Besong","sequence":"additional","affiliation":[{"name":"District Hospital Kumba, Meme Division, South-West Region, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella A","family":"Sama","sequence":"additional","affiliation":[{"name":"District Hospital Ndop, Ngoketunjia Division, North-West Region, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Orock","sequence":"additional","affiliation":[{"name":"Regional Hospital Ngaoundere, Avenue Rue Ahidjo Ngaound\u00e9r\u00e9, Adamawa, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D","family":"Kouyos","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huldrych F","family":"G\u00fcnthard","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J","family":"Metzner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, R\u00e4mistrasse 100, CH-8091 Zurich, Switzerland"},{"name":"Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,7]]},"reference":[{"key":"key\n\t\t\t\t20180618203521_dky103-B1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study","volume":"366","author":"Sterne","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618203521_dky103-B2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cid\/ciw128","article-title":"Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: a 15-year prospective cohort analysis","volume":"62","author":"Scherrer","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B5","author":"WHO"},{"key":"key\n\t\t\t\t20180618203521_dky103-B6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180618203521_dky103-B8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180618203521_dky103-B9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first line antiretroviral therapy","volume":"22","author":"Peuchant","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B10","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/QAD.0000000000000397","article-title":"Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients","volume":"28","author":"Metzner","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/dku470","article-title":"Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon","volume":"70","author":"Zoufaly","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180618203521_dky103-B12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/jix338","article-title":"Prevalence of drug-resistant minority variants in untreated HIV-1-infected individuals with and those without transmitted drug resistance detected by Sanger sequencing","volume":"216","author":"Clutter","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B13","author":"UNAIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B14","doi-asserted-by":"crossref","first-page":"e0129210","DOI":"10.1371\/journal.pone.0129210","article-title":"Monitoring HIV drug resistance early warning indicators in Cameroon: a study following the revised World Health Organization recommendations","volume":"10","author":"Fokam","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618203521_dky103-B15","author":"WHO"},{"key":"key\n\t\t\t\t20180618203521_dky103-B16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.00428-07","article-title":"Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B","volume":"46","author":"Ndembi","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32834bbbe9","article-title":"Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients","volume":"25","author":"Aghokeng","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B18","doi-asserted-by":"crossref","first-page":"e72680.","DOI":"10.1371\/journal.pone.0072680","article-title":"Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performance","volume":"8","author":"Billong","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618203521_dky103-B19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/aid.2006.22.812","article-title":"HIV genetic diversity in Cameroon: possible public health importance","volume":"22","author":"Ndongmo","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180618203521_dky103-B20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/aid.2006.22.453","article-title":"HIV-1 Group N: evidence of ongoing transmission in Cameroon","volume":"22","author":"Yamaguchi","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180618203521_dky103-B21","author":"WHO"},{"key":"key\n\t\t\t\t20180618203521_dky103-B22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2016.11.008","article-title":"MinVar: a rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing","volume":"240","author":"Huber","year":"2017","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20180618203521_dky103-B23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618203521_dky103-B24","doi-asserted-by":"crossref","first-page":"e4724.","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618203521_dky103-B25","author":"WHO"},{"key":"key\n\t\t\t\t20180618203521_dky103-B26","doi-asserted-by":"crossref","first-page":"e74249.","DOI":"10.1371\/journal.pone.0074249","article-title":"Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination","volume":"8","author":"Di Giallonardo","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180618203521_dky103-B27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1515\/CCLM.2009.351","article-title":"Quantitation of RNA decay in dried blood spots during 20 years of storage","volume":"47","author":"Gauffin","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"key\n\t\t\t\t20180618203521_dky103-B28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4236\/wja.2013.33033","article-title":"Use of dried blood spot to improve the diagnosis and management of HIV in resource-limited settings","volume":"3","author":"Adawaye","year":"2013","journal-title":"World J AIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/JCM.02255-08","article-title":"Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing","volume":"47","author":"Monleau","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JCM.02016-06","article-title":"Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing","volume":"45","author":"McNulty","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jcv.2009.11.006","article-title":"Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay","volume":"47","author":"Andreotti","year":"2010","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.qai.0000226793.16216.55","article-title":"Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon","volume":"43","author":"Koizumi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180618203521_dky103-B33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/135965350801302S10","article-title":"A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings","volume":"13","author":"Myatt","year":"2008","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180618203521_dky103-B34","first-page":"132","article-title":"2017 Update of the drug resistance mutations in HIV-1","volume":"24","author":"Wensing","year":"2017","journal-title":"Top Antivir Med"},{"key":"key\n\t\t\t\t20180618203521_dky103-B35","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/JCM.00634-17","article-title":"Multimethod longitudinal HIV drug resistance analysis in antiretroviral-therapy-naive patients","volume":"55","author":"Nanfack","year":"2017","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B36","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/cit125","article-title":"Clinical implications of HIV-1 minority variants","volume":"56","author":"Li","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/QAD.0b013e32831d2a81","article-title":"A public health model for the molecular surveillance of HIV transmission in San Diego, California","volume":"23","author":"Smith","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180618203521_dky103-B38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/651951","article-title":"Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland","volume":"201","author":"Kouyos","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cit694","article-title":"Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV cohort study","volume":"58","author":"Drescher","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmii.2014.08.002","article-title":"Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan","volume":"49","author":"Weng","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t20180618203521_dky103-B41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jac\/dkn412","article-title":"Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance","volume":"62","author":"Buckton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180618203521_dky103-B42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jcv.2012.01.010","article-title":"Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes","volume":"54","author":"Aitken","year":"2012","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/cid\/cis015","article-title":"Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy","volume":"54","author":"Rottinghaus","year":"2012","journal-title":"Clinical Infectious Diseases"},{"key":"key\n\t\t\t\t20180618203521_dky103-B44","doi-asserted-by":"crossref","first-page":"185.","DOI":"10.1186\/1743-422X-8-185","article-title":"Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon","volume":"8","author":"Ragupathy","year":"2011","journal-title":"Virol J"},{"key":"key\n\t\t\t\t20180618203521_dky103-B45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jmv.23846","article-title":"The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations","volume":"86","author":"Agyingi","year":"2014","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180618203521_dky103-B46","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucl Acids Symp Ser"},{"key":"key\n\t\t\t\t20180618203521_dky103-B47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virol.2004.05.022","article-title":"Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol","volume":"326","author":"Rusert","year":"2004","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180618203521_dky103-B48","doi-asserted-by":"crossref","first-page":"62.","DOI":"10.1186\/s12977-016-0299-0","article-title":"Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs","volume":"13","author":"Oberle","year":"2016","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20180618203521_dky103-B49","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/cid\/cir725","article-title":"Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection","volume":"53","author":"Rieder","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618203521_dky103-B50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bioinformatics\/16.4.400","article-title":"Detecting hypermutations in viral sequences with an emphasis on G\u2192A hypermutation","volume":"16","author":"Rose","year":"2000","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180618203521_dky103-B51","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180618203521_dky103-B52","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180618203521_dky103-B53","doi-asserted-by":"crossref","first-page":"e9490.","DOI":"10.1371\/journal.pone.0009490","article-title":"FastTree 2\u2014approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/7\/1917\/25034403\/dky103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T19:52:41Z","timestamp":1660593161000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/7\/1917\/4964716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,7]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,7]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky103","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,4,7]]}}}